Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Fahrettin Covut, MD, Ramsha Ahmed, MD, Christy J. Samaras, DO, Faiz Anwer, MD, Alex V. Mejia Garcia, MD, Dana E Angelini, MD, Beth M. Faiman, PhDCNP, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Saveta Mathur, CNP, Kimberly Hamilton, APRN/PA, Nathaniel Rosko, PharmD, Jason Valent, MD, Jack Khouri, MD

Blood (2019) 134 (Supplement_1): 3148.

https://doi.org/10.1182/blood-2019-131400

Published: 2019

Journal Articles

Aspirin Use in Venous Thromboembolism Prophylaxis Following Hip or Knee Arthroplasty: A Network Meta-Analysis of Randomized Controlled Trials

Tarek Haykal, MD, Babikir Kheiri, MD, Mahmoud Barbarawi, MD, Yazan Zayed, MD, Muhammad Shah Miran, MD, Adam Chahine, MD, Ahmed Abdalla, MD, Khalil Katato, MD, Ghassan Bachuwa, MD MHSA, MS, Tarik Hadid, MD MS, Zyad Kafri, MDMS

Blood (2018) 132 (Supplement 1): 1240.

https://doi.org/10.1182/blood-2018-99-118635

Published: 2018

Journal Articles

Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia

Blood (2017) 130 (Supplement 1): 3506.

https://doi.org/10.1182/blood.V130.Suppl_1.3506.3506

Published: 2017

Journal Articles

Response to Ponatinib in Patients with Chronic Myeloid Leukaemia (CML), the Tawam (tertiary care referral hospital UAE) Experience

Arif Alam, MBBS, Jorgen Kristensen, MD PhD

Blood (2017) 130 (Supplement 1): 5262.

https://doi.org/10.1182/blood.V130.Suppl_1.5262.5262

Published: 2017

Journal Articles

Predictors of Vascular Events and Disease Transformation in Chinese Patients with Myeloproliferative Neoplasms during Long-Term Follow-up

Garret MK Leung, Jamilla Li, MBBS, MRCP, Karen Tang, MBBS, MRCP, Rita Yim, Ho-Wan Ip, MBBS,FRCPA, Jason Chi Chiu So, FRCPath,MBBS, Rock Y.Y. Leung, Clarence C.K. Lam, Yok-Lam Kwong, Harinder Gill, MDFRCP,MBBS,MRCP

Blood (2017) 130 (Supplement 1): 5273.

https://doi.org/10.1182/blood.V130.Suppl_1.5273.5273

Published: 2017

Journal Articles

Lenalidomide Combined with R-CHOP (R2CHOP) Overcomes Negative Prognostic Impact of ABC Molecular Subtype in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Grzegorz S. Nowakowski, MD, Betsy R. Laplant, MS, Levi Pederson, Matthew J Maurer, MS, William R. Macon, MD, Rebecca L King, MD, James Storhoff, Shannon Dennis, Anita K. Gandhi, PhD, Anjan Thakurta, PhD, Patrick R. Hagner, Lisa Rimsza, MD, Thomas M. Habermann, James R Cerhan, MD PhD, Thomas E. Witzig, MD

Blood (2016) 128 (22): 3035.

https://doi.org/10.1182/blood.V128.22.3035.3035

Published: 2016

Journal Articles

Bleeding and Thrombotic Complications of Pediatric Liver Transplant

Alexandra J. Borst, MD, Debra L Sudan, MD, Laura A Wang, MIPH, Michael J Neuss, PhD, Tracy G Spears, MS, RN, Thomas L Ortel, MD PhD

Blood (2016) 128 (22): 1005.

https://doi.org/10.1182/blood.V128.22.1005.1005

Published: 2016

Journal Articles

Efficacy of Carfilzomib (K), Pomalidomide (P), and Dexamethasone (d) in Heavily Pretreated Patients with Relapsed/ Refractory Multiple Myeloma (RRMM) in a Real World Setting

Miriam Hobbs, CNP, Jonas Paludo, MD, Amie Fonder, PA-C, Jithma P Abeykoon, MD, Morie A. Gertz, MD, S. Vincent Rajkumar, MD, Ronald S. Go, MD, Francis K Buadi, MD, Martha Q. Lacy, MD, Nelson Leung, MD, Angela Dispenzieri, MD, Wilson I Gonsalves, MD, David Dingli, MD PhD FRCP, Yi L. Hwa, DNP, Taxiarchis Kourelis, MD, Robert A. Kyle, MD, Shaji Kumar, MD, Prashant Kapoor, MD

Blood (2016) 128 (22): 3337.

https://doi.org/10.1182/blood.V128.22.3337.3337

Published: 2016

Journal Articles

Results of an Upfront Myeloma Carepath Pilot with Response-Adapted Therapy

Mayur Narkhede, MD, Jason Valent, MD, Chad Cummings, MBA, Katherine Glass, MPH, MS, Debbie Hastings, Beth Faiman, PhD, CNP, Kimberly Hamilton, CNP, Janice Reed, RN, Mary Ann Karam, RN, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Mitchell R. Smith, MD PhD, Hien K. Duong, MD, Christy Samaras, DO, Frederic J. Reu, MD

Blood (2014) 124 (21): 2620.

https://doi.org/10.1182/blood.V124.21.2620.2620

Published: 2014

Journal Articles

Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution

Houry Leblebjian, PharmD, BCOP, Wanling Xie, MS, Paul G. Richardson, MD, Irene M. Ghobrial, MD, Christy Harris, PharmD, BCPS, BCOP, Robert L Schlossman, MD, Claudia E. Paba-Prada, MD, Nikhil C. Munshi, MD, Sylvia Bartel, R.Ph., M.H.P., Kenneth C. Anderson, MD, Edie A. Weller, PhD, Jacob P. Laubach, MD

Blood (2013) 122 (21): 1977.

https://doi.org/10.1182/blood.V122.21.1977.1977

Published: 2013

Journal Articles

Lenalidomide In Combination With R-CHOP (R2-CHOP) In Patients With High Burden Follicular Lymphoma: Phase 2 Study

Herve Tilly, MD, Franck Morschhauser, MD, PhD, Olivier Casasnovas, MD, Thierry Jo Molina, MD, PhD, Nicolas Mounier, MD, PhD, Gilles Andre Salles, MD, PhD, Steven Le Gouill, MD, PhD, Serge Bologna, MD, Olivier Tournilhac, MD, PhD, Jose Cabecadas, MD, Reda Bouabdallah, MD, Jean Gabarre, MD, Thierry Lamy, MD, PhD, Corinne Haioun, MD, PhD

Blood (2013) 122 (21): 248.

https://doi.org/10.1182/blood.V122.21.248.248

Published: 2013

Journal Articles

High-Dose Pomalidomide and Dexamethasone Induce Rapid Responses In Patients With AL Amyloidosis Exposed To Alkylators, Immune Modulatory Drugs, and Proteasome Inhibitors

Giovanni Palladini, MD, Paolo Milani, MD, Marta Vidus Rosin, MD, Andrea Foli, MD, Giampaolo Merlini, MD

Blood (2013) 122 (21): 288.

https://doi.org/10.1182/blood.V122.21.288.288

Published: 2013

Journal Articles

A 4-Drug, Weekly Combination Regimen of Bortezomib, Cyclophosphamide, Liposomal Doxorubicin, and Dexamethasone for Initial Treatment of Multiple Myeloma

Pamela S. Becker, MD, PhD, Ted A. Gooley, PhD, Kathy Lilleby, RN, Damian J. Green, MD, Nicholas Burwick, MD, Christine Wallace, Theodore Kim, DO, Kiarash Kojouri, MD, MPH, Erin Nelli, DO, William I. Bensinger, MD

Blood (2012) 120 (21): 5038.

https://doi.org/10.1182/blood.V120.21.5038.5038

Published: 2012

Journal Articles

Lenalidomide and Dexamethasone in the Treatment of AL Amyloidosis: Final Results of A Phase II Trial

Divya Nair, MD, Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Salli A Fennessey, Kathleen T Finn, ANP, Martha Skinner, MD, Jerome B. Zeldis, MD, PhD, David C Seldin, MD, PhD

Blood (2012) 120 (21): 4084.

https://doi.org/10.1182/blood.V120.21.4084.4084

Published: 2012

Journal Articles

Prospective Evaluation of the Risk of Thromboembolic Complications in Patients Treated with Lenalidomide-based Therapy and Genetic Associations

Tina Bagratuni, Efstathios Kastritis, Maria Roussou, Dimitrios Christoulas, Efthimios Kostouros, Marianna Politou, Evangelos Terpos, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 2872.

https://doi.org/10.1182/blood.V118.21.2872.2872

Published: 2011

Journal Articles

Phase I Study of Escalating Doses of Lenalidomide Combined with R-CHOP (R2-CHOP) for Front-Line Treatment of B-Cell Lymphomas

Herve Tilly, Franck Morschhauser, Gilles Andre Salles, Rene-Olivier Casasnovas, Serge Bologna, Thierry Jo Molina, Corinne Haioun, Bertrand Coiffier

Blood (2011) 118 (21): 1632.

https://doi.org/10.1182/blood.V118.21.1632.1632

Published: 2011

Journal Articles

Clinical Efficacy of a Bortezomib, Cyclophosphamide and Dexamethasone Compared with Bortezomib, Cyclophosphamide, Thalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD, PhD, Sung-Hoon Jung, MD, Soo-Young Bae, MD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung-Joon Kim, Je-Jung Lee, MD, PhD, The Korean Multiple Myeloma Working Party KMMWP

Blood (2011) 118 (21): 1868.

https://doi.org/10.1182/blood.V118.21.1868.1868

Published: 2011

Journal Articles

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)

Jeffrey A. Zonder, John Crowley, Mohamad A. Hussein, Vanessa Bolejack, Dennis F. Moore, Sr, Brock F. Whittenberger, Muneer H. Abidi, Brian G. M. Durie, Bart Barlogie

Blood (2010) 116 (26): 5838–5841.

https://doi.org/10.1182/blood-2010-08-303487

Published: 2010

Includes: Supplemental data

Journal Articles

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

Giovanni Palladini, MD, PhD, Paola Russo, MD, Paolo Milani, MD, Andrea Foli, MD, Letizia Zenone Bragotti, MD, Laura Obici, MD, Francesca Lavatelli, MD, Silvia Brugnatelli, MD, Vittorio Perfetti, MD, PhD, Rosangela Invernizzi, MD, Giampaolo Merlini, MD

Blood (2010) 116 (21): 3062.

https://doi.org/10.1182/blood.V116.21.3062.3062

Published: 2010

Journal Articles

Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients

Attaya Suvannasankha, Sherif Farag, MD, PhD, FRACP, FRCPA, Robin Obryant, RN, Lisa l Wood, RN, Nicole Porter, Rafat Abonour, MD

Blood (2010) 116 (21): 1970.

https://doi.org/10.1182/blood.V116.21.1970.1970

Published: 2010

NARROW

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Aspirin Use in Venous Thromboembolism Prophylaxis Following Hip or Knee Arthroplasty: A Network Meta-Analysis of Randomized Controlled Trials

Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia

Response to Ponatinib in Patients with Chronic Myeloid Leukaemia (CML), the Tawam (tertiary care referral hospital UAE) Experience

Predictors of Vascular Events and Disease Transformation in Chinese Patients with Myeloproliferative Neoplasms during Long-Term Follow-up

Lenalidomide Combined with R-CHOP (R2CHOP) Overcomes Negative Prognostic Impact of ABC Molecular Subtype in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Bleeding and Thrombotic Complications of Pediatric Liver Transplant

Efficacy of Carfilzomib (K), Pomalidomide (P), and Dexamethasone (d) in Heavily Pretreated Patients with Relapsed/ Refractory Multiple Myeloma (RRMM) in a Real World Setting

Results of an Upfront Myeloma Carepath Pilot with Response-Adapted Therapy

Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution

Lenalidomide In Combination With R-CHOP (R2-CHOP) In Patients With High Burden Follicular Lymphoma: Phase 2 Study

High-Dose Pomalidomide and Dexamethasone Induce Rapid Responses In Patients With AL Amyloidosis Exposed To Alkylators, Immune Modulatory Drugs, and Proteasome Inhibitors

A 4-Drug, Weekly Combination Regimen of Bortezomib, Cyclophosphamide, Liposomal Doxorubicin, and Dexamethasone for Initial Treatment of Multiple Myeloma

Lenalidomide and Dexamethasone in the Treatment of AL Amyloidosis: Final Results of A Phase II Trial

Prospective Evaluation of the Risk of Thromboembolic Complications in Patients Treated with Lenalidomide-based Therapy and Genetic Associations

Phase I Study of Escalating Doses of Lenalidomide Combined with R-CHOP (R2-CHOP) for Front-Line Treatment of B-Cell Lymphomas

Clinical Efficacy of a Bortezomib, Cyclophosphamide and Dexamethasone Compared with Bortezomib, Cyclophosphamide, Thalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only